Related Experiment Video
Updated: Oct 11, 2025

09:53
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.4K
The microenvironment of brain metastases from solid tumors.
Ethan S Srinivasan1, Krutika Deshpande2, Josh Neman3
1Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina, USA.
Neuro-Oncology Advances
|December 3, 2021
Summary
Brain metastasis (BrM) presents significant therapeutic challenges due to the unique brain tumor microenvironment (TME). Understanding the TME is key to developing effective treatments for this unmet medical need.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Immunology
Background:
- Brain metastasis (BrM) is a severe complication of cancer with poor prognosis.
- The brain tumor microenvironment (TME) presents unique biological and physical barriers to treatment.
- Current therapies often fail due to the TME's resistance mechanisms.
Purpose of the Study:
- To review the unique characteristics of the brain TME in the context of brain metastases.
- To explore the interplay between cancer cells and the CNS TME.
- To identify therapeutic opportunities within the TME for BrM.
Main Methods:
- Literature review of studies on brain metastasis and the TME.
- Analysis of the biological, immunological, and metabolic đặc điểm of the CNS TME.
- Synthesis of information on cancer cell adaptation within the CNS.
Main Results:
- The TME includes the blood-brain barrier, unique immune cells, specific metabolic conditions, and distinct intercellular interactions.
- Cancer cells exploit CNS vulnerabilities for proliferation.
- The TME significantly contributes to treatment resistance and poor outcomes in BrM.
Conclusions:
- The TME is a critical determinant of BrM progression and treatment response.
- Targeting the unique aspects of the brain TME offers promising avenues for novel BrM therapies.
- Further research into the TME is essential for improving patient outcomes.
Related Concept Videos
The Tumor Microenvironment
6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
Metastasis
5.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K

